EFTA02625740.pdf

From: Sent: T urs a , Janua 17, 2019 422 AM To: Subject: Catching Up Dear Jeffrey I hope you've been well. = wanted to update you on what I've been up to for the last two years. I wa= also hoping to talk with you to see if I might use the foundation's Lexin=ton office conference room from time to time for my work and what I could =rovide in exchange for that. I am cc'ing Rich because I'm not sure if you =till use this email? Since workin for our found=tion I continued to ublish as a 'ournalis Regenerative medicine is a =apidly evolving field, and one that forces the medical industry to shift t=eir focus from addressing symptoms of disease to fundamental evolutionary =hortfalls. The co=cept of the latter gene vector is really intriguing in that a master trans=ription gene completely restored liver function by rebalancing genetic exp=ession and thus proteostasis. While I don't reall= need an office at this point, I do need access to a conference room from =ime to time and it would be hugely helpful if I could access the foundatio='s. If there was some work that I could do for the foundation in exchange,=l would be delighted to do that. It would be wond=rful to catch up with you as well. all the best,<=div> =br> Dire=tor of Genetic Therapies BioHebe LLC cell: email: www.biohebe.com @BioHebe <http://www.twitter.com/biohebe> </=ont> EFTA_R1_01838010 EFTA02625740 2 EFTA_R1_01838011 EFTA02625741